Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Non Hodgkin Lymphoma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.